PancreaSeq® - Pancreatic Cyst Fluid NGS Analysis

PancreaSeq - Pancreatic Cyst Fluid NGS Analysis

PancreaSeq Advantage

  • Simultaneous sequencing and detection of genomic alterations in 22 pancreatic cancer-related genes
  • Test pre-surgical cyst fluid without need for cytopathology analysis
  • Fast Turnaround Time

Test Details

  • PancreaSeq utilizes an amplification-based targeted next generation sequencing of DNA isolated from cyst fluid
  • PancreaSeq detects single nucleotide variants (SNVs) and insertions/deletions (indels) in targeted regions of 20 pancreatic cancer-related genes, and copy number alterations in 4 genes
  • PancreaSeq aids in the diagnosis of pancreatic cysts including pseudocysts, serous cystadenomas (SCAs), intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms (MCNs)
  • It has a fast turnaround time (7-10 days)

Genes Assayed by PancreaSeq

Background

Examples of GlioSeq Reports

Specimen Requirements and Shipping Instructions